- Home
- HUMA vs EQV Comparison
HUMA vs EQV Comparison
Compare HUMA & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- EQV
- Stock Information
- Founded
- HUMA 2004
- EQV 2024
- Country
- HUMA United States
- EQV United States
- Employees
- HUMA N/A
- EQV N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- EQV
- Sector
- HUMA Health Care
- EQV
- Exchange
- HUMA Nasdaq
- EQV Nasdaq
- Market Cap
- HUMA 427.2M
- EQV 448.4M
- IPO Year
- HUMA N/A
- EQV 2024
- Fundamental
- Price
- HUMA $1.28
- EQV $10.10
- Analyst Decision
- HUMA Strong Buy
- EQV
- Analyst Count
- HUMA 6
- EQV 0
- Target Price
- HUMA $14.60
- EQV N/A
- AVG Volume (30 Days)
- HUMA 5.7M
- EQV 18.3K
- Earning Date
- HUMA 05-09-2025
- EQV 01-01-0001
- Dividend Yield
- HUMA N/A
- EQV N/A
- EPS Growth
- HUMA N/A
- EQV N/A
- EPS
- HUMA N/A
- EQV N/A
- Revenue
- HUMA N/A
- EQV N/A
- Revenue This Year
- HUMA N/A
- EQV N/A
- Revenue Next Year
- HUMA $1,217.58
- EQV N/A
- P/E Ratio
- HUMA N/A
- EQV $49.12
- Revenue Growth
- HUMA N/A
- EQV N/A
- 52 Week Low
- HUMA $1.18
- EQV $9.88
- 52 Week High
- HUMA $9.97
- EQV $10.18
- Technical
- Relative Strength Index (RSI)
- HUMA 20.12
- EQV N/A
- Support Level
- HUMA $1.31
- EQV N/A
- Resistance Level
- HUMA $3.36
- EQV N/A
- Average True Range (ATR)
- HUMA 0.21
- EQV 0.00
- MACD
- HUMA -0.11
- EQV 0.00
- Stochastic Oscillator
- HUMA 0.24
- EQV 0.00
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.